Why the study?
The study aimed to determine the predictive value of cardiopulmonary exercise testing in the prognosis of patients with acute coronary syndrome treated with percutaneous coronary intervention.
Do cardiopulmonary exercise testing parameters predict major adverse cardiac events in patients with acute coronary syndrome after percutaneous coronary intervention?
Do cardiopulmonary exercise testing parameters predict major adverse cardiac events in patients with acute coronary syndrome after percutaneous coronary intervention?
Cardiopulmonary exercise testing parameters demonstrate high predictive value for major adverse cardiac events in patients with ACS following PCI.
CPX may aid post-PCI risk stratification in ACS; leaves open incremental value and need for prospective validation.
OBJECTIVES: We aimed to determine the predictive value of cardiopulmonary exercise testing (CPX) in the prognosis of patients with acute coronary syndrome (ACS) treated with percutaneous coronary intervention (PCI). METHODS: We conducted a retrospective study including patients who underwent CPX within 1 year of PCI between September 2012 and October 2017. Patients were followed-up until the occurrence of a major adverse cardiac event (MACE) or administrative censoring (September 2019). A Cox regression model was used to identify significant predictors of a MACE. Model performance was evaluated in terms of discrimination (C-statistic) and calibration (calibration-in-the-large). RESULTS: In total, 184 patients were included and followed-up for a median 51 months (interquartile range: 36-67 months) and 32 events occurred. Multivariable analysis revealed that body mass index and Gensini score were significant predictors of a MACE. Four CPX-related variables were found to be predictive of a MACE: premature CPX termination, peak oxygen uptake, heart rate reserve, and ventilatory equivalent for carbon dioxide slope. The final prediction model had a C-statistic of 0.92 and calibration-in-the-large 0.58%. CONCLUSION: CPX-related parameters may have high predictive value for poor outcomes in patients with ACS who undergo PCI, indicating a need for appropriate treatment and timely management.
No takes yet. Share an insight, caveat, or question.
Niu et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: